Rocket


News + Filings
Transactions





PRASAD SUYASH

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
07/06/2022Taysha Gene Therapies, Inc. SaleCommon Stock9k$3.79$33.9k 07/05/2022
07/05/2022Taysha Gene Therapies, Inc. SaleCommon Stock3.9k$3.51$13.7k 07/05/2022
07/01/2022Taysha Gene Therapies, Inc. SaleCommon Stock23.9k$3.53$84.4k 06/29/2022
06/30/2022Taysha Gene Therapies, Inc. SaleCommon Stock13.9k$3.72$51.7k 06/29/2022
06/29/2022Taysha Gene Therapies, Inc. SaleCommon Stock12.3k$3.81$47k 06/29/2022
04/06/2022Taysha Gene Therapies, Inc. GrantEmployee Stock Option (right to buy)40.3k$6.52$262.9k 04/06/2022
02/23/2022Taysha Gene Therapies, Inc. GrantEmployee Stock Option (right to buy)80.6k$5.96$480.7k 02/23/2022
07/01/2021Taysha Gene Therapies, Inc. SaleCommon Stock19.7k$21.12$416.2k 06/29/2021
06/30/2021Taysha Gene Therapies, Inc. SaleCommon Stock6.2k$22.44$139.2k 06/29/2021
06/30/2021Taysha Gene Therapies, Inc. SaleCommon Stock500$23.70$11.8k 06/29/2021
06/30/2021Taysha Gene Therapies, Inc. SaleCommon Stock13.4k$21.42$286.5k 06/29/2021
06/29/2021Taysha Gene Therapies, Inc. SaleCommon Stock300$25.19$7.6k 06/29/2021
06/29/2021Taysha Gene Therapies, Inc. SaleCommon Stock3.9k$24.46$94.5k 06/29/2021
06/29/2021Taysha Gene Therapies, Inc. SaleCommon Stock35.1k$23.74$832.2k 06/29/2021
01/19/2021Taysha Gene Therapies, Inc. GrantStock Option (Right to Buy)80k$31.00$2.5M 01/19/2021
09/28/2020Taysha Gene Therapies, Inc. ConversionCommon Stock3.8k$0.00$0 09/28/2020
09/28/2020Taysha Gene Therapies, Inc. ConversionSeries B Preferred Stock3.5k$0.00$0 09/28/2020
09/23/2020Taysha Gene Therapies, Inc. GrantCommon Stock668.7k$0.00$0 09/23/2020
06/05/2019Audentes Therapeutics, Inc.BOLDPayment of ExerciseCommon Stock757$37.31$28.2k 06/05/2019
05/13/2019Audentes Therapeutics, Inc.BOLDExerciseStock Option (right to buy)10k$0.79$7.9k 05/13/2019
05/13/2019Audentes Therapeutics, Inc.BOLDSaleCommon Stock54$37.72$2k 05/13/2019
05/13/2019Audentes Therapeutics, Inc.BOLDSaleCommon Stock9.9k$36.98$367.8k 05/13/2019
02/25/2019Audentes Therapeutics, Inc.BOLDSaleCommon Stock10k$30.06$300.6k 02/25/2019
02/25/2019Audentes Therapeutics, Inc.BOLDExerciseStock Option (right to buy)10k$0.79$7.9k 02/25/2019
02/06/2019Audentes Therapeutics, Inc.BOLDGrantStock Option (right to buy)48.8k$24.74$1.2M 02/06/2019
02/06/2019Audentes Therapeutics, Inc.BOLDGrantCommon Stock17.5k$0.00$0 02/06/2019
11/15/2018Audentes Therapeutics, Inc.BOLDGrantCommon Stock736$19.64$14.5k 11/15/2018
10/01/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock1.1k$38.85$42.8k 10/01/2018
10/01/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock100$39.52$4k 10/01/2018
10/01/2018Audentes Therapeutics, Inc.BOLDExerciseStock Option (right to buy)10k$0.79$7.9k 10/01/2018
10/01/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock4.7k$35.60$167.3k 10/01/2018
10/01/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock200$36.32$7.3k 10/01/2018
10/01/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock3.9k$37.82$147.5k 10/01/2018
07/02/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock5k$38.02$189.7k 07/02/2018
07/02/2018Audentes Therapeutics, Inc.BOLDSaleCopmmon Stock5k$38.79$194.4k 07/02/2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy